Translate
About
Carsgen Therapeutics Holdings Ltd (HK:2171) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 6 2026
CARsgen Therapeutics Announces 2025 Annual Results
Feb 13 2026
CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai
Jan 12 2026
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Jan 12 2026
Dispatch Bio and CARsgen Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Dec 29 2025
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
Financials
Revenue
HK$125.66 M
Market Cap
HK$10.07 B
EPS
-0.95